# EDGAR Filing Document

**Accession Number:** 0001686016
**File Stem:** 0001104659-23-023371
**Filing Date:** 2023-2
**Character Count:** 16548
**Document Hash:** c9ebd24088a5bd53066abab9b22a1d0b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-023371.hdr.sgml**: 20230221

**ACCESSION NUMBER**: 0001104659-23-023371

**CONFORMED SUBMISSION TYPE**: SC TO-T/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230221

**DATE AS OF CHANGE**: 20230217

**GROUP MEMBERS**: ABP ACQUISITION 2 LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AlerisLife Inc.
- **CENTRAL INDEX KEY:** 0001159281
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-SKILLED NURSING CARE FACILITIES [8051]
- **IRS NUMBER:** 043516029
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13E3/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-62369
- **FILM NUMBER:** 23644226

**BUSINESS ADDRESS:**
- **STREET 1:** 400 CENTRE STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458
- **BUSINESS PHONE:** (617) 796 8387

**MAIL ADDRESS:**
- **STREET 1:** 400 CENTRE STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR SENIOR LIVING INC.
- **DATE OF NAME CHANGE:** 20170306

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR QUALITY CARE, INC.
- **DATE OF NAME CHANGE:** 20161006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR QUALITY CARE INC
- **DATE OF NAME CHANGE:** 20010918
**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AlerisLife Inc.
- **CENTRAL INDEX KEY:** 0001159281
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-SKILLED NURSING CARE FACILITIES [8051]
- **IRS NUMBER:** 043516029
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-T/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-62369
- **FILM NUMBER:** 23644225

**BUSINESS ADDRESS:**
- **STREET 1:** 400 CENTRE STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458
- **BUSINESS PHONE:** (617) 796 8387

**MAIL ADDRESS:**
- **STREET 1:** 400 CENTRE STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR SENIOR LIVING INC.
- **DATE OF NAME CHANGE:** 20170306

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR QUALITY CARE, INC.
- **DATE OF NAME CHANGE:** 20161006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIVE STAR QUALITY CARE INC
- **DATE OF NAME CHANGE:** 20010918
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ABP Acquisition LLC
- **CENTRAL INDEX KEY:** 0001686016
- **IRS NUMBER:** 813995762
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-T/A

**BUSINESS ADDRESS:**
- **STREET 1:** TWO NEWTON PLACE
- **STREET 2:** 255 WASHINGTON STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458
- **BUSINESS PHONE:** 617-796-8390

**MAIL ADDRESS:**
- **STREET 1:** TWO NEWTON PLACE
- **STREET 2:** 255 WASHINGTON STREET
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02458

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION** **<br> Washington, D.C. 20549**

**SCHEDULE TO**

**TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)<br> OF THE SECURITIES EXCHANGE ACT OF 1934**

**(Amendment No. 1)**

**ALERISLIFE INC.**

(Name of Subject Company (Issuer))

**ABP ACQUISITION 2 LLC**

**a wholly owned subsidiary of**

**ABP ACQUISITION LLC**

(Names of Filing Persons (Offeror))

**Common Stock, Par Value $0.01 Per Share**

(Title of Class of Securities)

**33832D205**

(Cusip Number of Class of Securities)

**Adam D. Portnoy<br> President<br> ABP Acquisition LLC<br> 255 Washington Street<br> Newton, MA 02458<br> (617) 928-1300**

(Name, Address and Telephone Number of Person Authorized to<br> Receive Notices and Communications on Behalf of Filing Persons)

**Copies to:**

**Faiz Ahmad<br> Skadden, Arps, Slate, Meagher & Flom LLP<br> 920 North King Street<br> Wilmington, DE 19801<br> (302) 651-3250**

**CALCULATION OF FILING FEE**

---

| | |
|:---|:---|
| **Transaction Valuation\*** | &nbsp;&nbsp;**Amount of Filing Fee\*\*** |
| $41225242 | $4543.02 |

---

\* Estimated for purposes of calculating the filing fee only. The transaction valuation was calculated as the difference between 33,442,433, the number of shares of common stock of AlerisLife Inc., par value $0.01 per share ("Shares"), outstanding as of February 16, 2023, and 1,972,783, the number of Shares owned by ABP Acquisition LLC or by any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser, multiplied by $1.31. The calculation of the filing fee is based on information provided by AlerisLife Inc. as of February 16, 2023.

\*\* The filing fee was calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory No. 1 for Fiscal Year 2023, by multiplying the transaction value by 0.00011020.

⌧ Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting
fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing.

---

| | | | |
|:---|:---|:---|:---|
| Amount Previously Paid: | $4543.02 | Filing Party: | ABP Acquisition 2 LLC and ABP Acquisition LLC |
| Form or Registration No.: | Schedule TO | Date Filed: | February 17, 2023 |

---

◻ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

⌧ third-party tender offer subject to Rule 14d-1.

◻ issuer tender offer subject to Rule 13e-4.

⌧ going-private transaction subject to Rule 13e-3.

◻ amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer. ◻

This Amendment No. 1 amends and supplements the Tender Offer Statement on Schedule TO, filed by ABP Acquisition 2 LLC, a Maryland limited liability company ("Purchaser"), and ABP Acquisition LLC, a Maryland limited liability company ("Parent"), with the U.S. Securities and Exchange Commission on February 17, 2023 (together with any subsequent amendments and supplements thereto, the "Schedule TO"). The Schedule TO relates to the offer by Purchaser to purchase all outstanding shares of common stock, $0.01 par value per share ("Shares"), of AlerisLife Inc., a Maryland corporation ("ALR") (other than Shares held by Parent, Purchaser, any other direct or indirect wholly owned subsidiary of Parent or any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser), at a price of $1.31 per Share, net to the seller in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated February 17, 2023 (together with any amendments or supplements thereto, the "Offer to Purchase") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto and with the Offer to Purchase, the "Offer"), copies of which are incorporated by reference to Exhibits (a)(1)(i) and (a)(1)(ii) of the Schedule TO respectively.

The information set forth in the Offer to Purchase, including all schedules thereto, is hereby expressly incorporated by reference in response to all of the items of the Schedule TO, including, without limitation, all of the information required by Schedule 13E-3 that is not included in or covered by the items in Schedule TO, and is supplemented by the information specifically provided herein, except as otherwise set forth below. Capitalized terms used but not defined herein have the applicable meanings ascribed to them in the Schedule TO or the Offer to Purchase.

**Item 12. Exhibits.**

Item 12 of the Schedule TO is hereby amended and supplemented by adding the following exhibit:

---

| | |
|:---|:---|
| **Exhibit<br> No.** |  |
| [(a)(5)(iii)](tm236939d4_ex99-a5iii.htm) | [Notice of Merger of ABP Acquisition 2 LLC with and into AlerisLife Inc., issued on February 17, 2023](tm236939d4_ex99-a5iii.htm) |

---

**SIGNATURE**

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 17, 2023

---

| | | |
|:---|:---|:---|
| By: | /s/ Adam D. Portnoy | /s/ Adam D. Portnoy |
|  | Name: | Adam D. Portnoy |
|  | Title: | *President of ABP Acquisition LLC* |
| By: | /s/ Adam D. Portnoy | /s/ Adam D. Portnoy |
|  | Name: | Adam D. Portnoy |
|  | Title: | *President of ABP Acquisition 2 LLC* |

---

## Ex-99.(A)(5)(Iii)

**Exhibit (a)(5)(iii)**

**NOTICE OF MERGER OF**

**ABP ACQUISITION 2 LLC**

**WITH AND INTO**

**ALERISLIFE INC.**

**PURSUANT TO SECTION 3-106.1(e)**

**OF THE MARYLAND GENERAL CORPORATION LAW**

**February 17, 2023**

Dear Stockholder of AlerisLife Inc.,

As previously announced, ABP Acquisition 2 LLC, a Maryland limited liability company ("<u>Purchaser</u>") and a wholly owned subsidiary of ABP Acquisition LLC, a Maryland limited liability company ("<u>Parent</u>"), is offering to purchase (the "<u>Offer</u>") all outstanding shares of common stock (other than Shares held by Parent, Purchaser, any other direct or indirect wholly owned subsidiary of Parent or any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser), par value $0.01 per share ("<u>Shares</u>"), of AlerisLife Inc., a Maryland corporation ("<u>ALR</u>"), at a price per Share of $1.31, net to the seller in cash, without interest and subject to any applicable withholding taxes. The Offer will be made in connection with the Agreement and Plan of Merger (together with any amendment, the "<u>Merger Agreement</u>"), dated as of February 2, 2023, among ALR, Parent and Purchaser.

Subject to the terms and conditions of the Merger Agreement, following the completion of the Offer and the satisfaction or waiver of certain conditions, Purchaser will be merged with and into ALR, without a meeting or vote of the ALR stockholders in accordance with Section 3-106.1 of the Maryland General Corporation Law (the "<u>MGCL</u>"), and ALR will be the surviving corporation and a wholly owned subsidiary of Parent (the "<u>Merger</u>").

**In accordance with Section 3-106.1(e) of the MGCL, notice of the Offer and the Merger and the other transactions contemplated by the Merger Agreement is hereby given by Purchaser to each stockholder of record of ALR as of the date of this notice (this "<u>Notice of Merger</u>"). The Articles of Merger, pursuant to which the Merger will become effective, will be filed for record with the State Department of Assessments and Taxation of Maryland not earlier than 20 business days after the date of this Notice of Merger.**

The Offer is subject to various conditions, including the "Minimum Tender Condition," which requires that the number of Shares validly tendered and not withdrawn together with any Shares beneficially owned by any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser or any wholly owned subsidiary of Parent, represents at least a majority of all then-outstanding Shares at the time of the expiration of the Offer. In accordance with Section 3-202(c) of the MGCL, holders of Shares are not entitled to exercise appraisal rights in connection with the Merger.

Purchaser and Parent have filed with the Securities and Exchange Commission (the "<u>SEC</u>"), and commenced mailing to each stockholder of ALR, materials relating to the Offer, including a Tender Offer Statement on Schedule TO, the Offer to Purchase, the related letter of transmittal and other Offer related materials. If you have questions about this Notice of Merger, the Offer or the Merger, you can call MacKenzie Partners, Inc., the information agent for the Offer, at (800) 322-2885.

**Notice to Investors and Security Holders**

This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities. Purchaser has filed a Tender Offer Statement on Schedule TO with the SEC containing an offer to purchase all of the outstanding shares of common stock of ALR not already owned by Purchaser or any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser for $1.31 per share and ALR has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the Offer. THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 CONTAIN IMPORTANT INFORMATION. ALR'S STOCKHOLDERS ARE URGED TO READ THESE DOCUMENTS CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES. The offer to purchase, the related letter of transmittal and the solicitation/recommendation statement are available free of charge at the SEC's website at <u>www.sec.gov</u>. Additional copies may be obtained for free by contacting Parent or ALR. Copies of the documents filed with the SEC by the Company will be available free of charge on ALR's internet website at https:/alerislife.com/ or by contacting ALR's investor relations contact at (617) 796-8245.

In addition to the offer to purchase, the related letter of transmittal and certain other tender offer documents filed by Purchaser, as well as the solicitation/recommendation statement filed by ALR, ALR will also file annual, quarterly, and current reports with the SEC as required prior to the Closing (as defined in the Merger Agreement) and for a limited period thereafter as may be required. ALR's filings with the SEC are available to the public from commercial document-retrieval services and at the website maintained by the SEC at <u>http://www.sec.gov</u>.

**Forward-Looking Statements**

Parent and ALR assume no obligation to update forward-looking statements contained in this communication as a result of new information or future events or developments except as required by law. This communication includes forward-looking statements regarding the proposed acquisition of ALR that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Any statement describing ALR's or Parent's goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties. Risks and uncertainties also include, among other things, risks related to the satisfaction or waiver of the conditions to closing the proposed acquisition in the anticipated timeframe or at all, including uncertainties as to how many of ALR's stockholders will tender their Shares in the Offer and the possibility that the acquisition does not close; disruption from the transaction making it more difficult to maintain business and operational relationships; and the magnitude of transaction costs. ALR's and Parent's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although ALR's and Parent's forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by ALR and Parent. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning ALR are described in additional detail in ALR's quarterly reports on Form 10-Q and annual reports on Form 10-K, which are on file with the SEC. Copies of these and other documents are available from ALR.

You should keep in mind that any forward-looking statement made in this notice speaks only as of the date on which it was made. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Purchaser and Parent. Purchaser and Parent do not undertake any obligation to update the information contained in this notice to reflect subsequently occurring events or circumstances except as may be required by law.

---

| |
|:---|
| Sincerely, |
| ABP Acquisition 2 LLC |
| Adam D. Portnoy |

---